Scarica l'app Stockscreener
2.00
4.31%
-0.09
Precedente Chiudi:
$2.09
Aprire:
$2.08
Volume 24 ore:
1.70M
Relative Volume:
0.66
Capitalizzazione di mercato:
$329.83M
Reddito:
$101.21M
Utile/perdita netta:
$-569.00K
Rapporto P/E:
-100.00
EPS:
-0.02
Flusso di cassa netto:
$-56.88M
1 W Prestazione:
-12.28%
1M Prestazione:
+7.53%
6M Prestazione:
+234.00%
1 anno Prestazione:
+60.00%
Intervallo 1D:
$2.00
$2.115
Intervallo di 1 settimana:
$2.00
$2.30
Portata 52W:
$0.40
$3.095
Cytomx Therapeutics Inc Stock (CTMX) Company Profile
Nome
Cytomx Therapeutics Inc
Settore
Industria
Telefono
650.515.3185
Indirizzo
151 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Confronta CTMX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTMX
Cytomx Therapeutics Inc
|
2.00 | 341.37M | 101.21M | -569.00K | -56.88M | -0.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Cytomx Therapeutics Inc Stock (CTMX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-31 | Iniziato | Oppenheimer | Outperform |
| 2025-05-15 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-04-14 | Ripresa | Piper Sandler | Overweight |
| 2024-05-28 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-05-09 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2024-05-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-04-22 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-11-14 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2022-07-07 | Downgrade | Jefferies | Buy → Hold |
| 2022-07-07 | Downgrade | Mizuho | Buy → Neutral |
| 2022-07-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-07-07 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-06-24 | Iniziato | BMO Capital Markets | Outperform |
| 2022-01-18 | Aggiornamento | Barclays | Underweight → Overweight |
| 2021-11-15 | Iniziato | BTIG Research | Buy |
| 2021-05-28 | Downgrade | Barclays | Equal Weight → Underweight |
| 2021-03-29 | Iniziato | JP Morgan | Overweight |
| 2021-03-23 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-22 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-06-01 | Downgrade | Jefferies | Buy → Hold |
| 2020-05-14 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-24 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2020-03-04 | Iniziato | Barclays | Equal Weight |
| 2019-11-20 | Iniziato | Guggenheim | Buy |
| 2019-11-11 | Downgrade | Wedbush | Outperform → Neutral |
| 2019-06-13 | Iniziato | Mizuho | Buy |
| 2019-05-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-03-11 | Iniziato | Barclays | Overweight |
| 2018-11-26 | Iniziato | Piper Jaffray | Overweight |
| 2018-10-15 | Iniziato | Goldman | Neutral |
| 2018-09-13 | Iniziato | H.C. Wainwright | Buy |
| 2018-06-01 | Iniziato | SunTrust | Buy |
| 2018-01-05 | Iniziato | Citigroup | Buy |
| 2017-09-08 | Iniziato | Wedbush | Outperform |
| 2017-03-27 | Iniziato | H.C. Wainwright | Buy |
| 2017-03-02 | Iniziato | Instinet | Buy |
| 2017-01-03 | Downgrade | Oppenheimer | Outperform → Perform |
| 2015-11-02 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Cytomx Therapeutics Inc Borsa (CTMX) Ultime notizie
CytomX Therapeutics (NASDAQ:CTMX) Shares Pass Below 50-Day Moving AverageShould You Sell? - MarketBeat
CytomX at Morgan Stanley Conference: Innovative Oncology Advances - Investing.com
Transcript : CytomX Therapeutics, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-10-2025 01 - MarketScreener
Is CytomX Therapeutics Inc. stock showing strong momentumVolume Spike & Technical Buy Zone Confirmations - Lancaster City Council
Can CytomX Therapeutics Inc. navigate macro headwindsJuly 2025 Macro Moves & Verified Trade Idea Suggestions - Lancaster City Council
Published on: 2025-09-09 06:04:45 - beatles.ru
RA Capital Management L.P. Invests $636,000 in CytomX Therapeutics, Inc. $CTMX - MarketBeat
CytomX Therapeutics Inc.’s volatility index tracking explained2025 Top Decliners & Safe Capital Growth Tips - Newser
How to recover losses in CytomX Therapeutics Inc. stockWeekly Trend Summary & Verified Momentum Stock Ideas - Newser
Is CytomX Therapeutics Inc. stock bottoming out2025 Pullback Review & Reliable Breakout Forecasts - Newser
CytomX Therapeutics Inc. Building a Base Near Support2025 Buyback Activity & Entry Point Strategy Guides - beatles.ru
Is CytomX Therapeutics Inc. forming higher highs and higher lowsBear Alert & Short-Term Swing Trade Alerts - خودرو بانک
Will CytomX Therapeutics Inc. benefit from AI trendsPortfolio Risk Summary & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Can CytomX Therapeutics Inc. maintain sales growthJuly 2025 Market Mood & Technical Buy Zone Confirmation - خودرو بانک
Identifying reversal signals in CytomX Therapeutics Inc.2025 Historical Comparison & Risk Controlled Daily Plans - Newser
News impact scoring models applied to CytomX Therapeutics Inc.July 2025 Spike Watch & Expert Approved Momentum Trade Ideas - Newser
How to forecast CytomX Therapeutics Inc. trends using time seriesJuly 2025 Gainers & Community Supported Trade Ideas - Newser
Should you hold or exit CytomX Therapeutics Inc. nowTrade Risk Assessment & Reliable Price Action Trade Plans - Newser
Historical volatility pattern of CytomX Therapeutics Inc. visualizedMarket Growth Summary & Free High Accuracy Swing Entry Alerts - Newser
Statistical indicators supporting CytomX Therapeutics Inc.’s strengthWeekly Loss Report & Consistent Return Strategy Ideas - Newser
Can you recover from losses in CytomX Therapeutics Inc.Market Movement Recap & Fast Entry Momentum Alerts - Newser
Is CytomX Therapeutics Inc. vulnerable to short sellersQuarterly Investment Review & Safe Capital Allocation Plans - خودرو بانک
Sentiment analysis tools applied to CytomX Therapeutics Inc.Quarterly Portfolio Report & Consistent Return Strategy Ideas - Newser
CytomX Therapeutics Inc. stock trend forecast2025 Macro Impact & AI Forecasted Stock Moves - Newser
Will CytomX Therapeutics Inc. stock recover after recent dropInsider Selling & Weekly Chart Analysis and Guides - Newser
Real time social sentiment graph for CytomX Therapeutics Inc.July 2025 Movers & High Accuracy Swing Entry Alerts - Newser
Technical analysis overview for CytomX Therapeutics Inc. stock2025 Bull vs Bear & Momentum Based Trading Signals - Newser
What institutional flow reveals about CytomX Therapeutics Inc.Market Performance Recap & Real-Time Sentiment Analysis - Newser
Is CytomX Therapeutics Inc. showing signs of accumulationJuly 2025 PreEarnings & Accurate Intraday Trade Tips - Newser
Will CytomX Therapeutics Inc. benefit from macro trends2025 Retail Activity & Stepwise Trade Signal Implementation - Newser
CytomX Therapeutics Inc. stock trendline breakdownJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - Newser
Leading vs lagging indicators on CytomX Therapeutics Inc. performanceMarket Growth Review & Accurate Technical Buy Alerts - Newser
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q2 2025 Earnings Call Transcript - MSN
Published on: 2025-09-03 09:30:47 - Newser
What earnings revisions data tells us about CytomX Therapeutics Inc.Weekly Stock Recap & Long-Term Growth Plans - Newser
Published on: 2025-09-03 13:30:24 - beatles.ru
What earnings revisions data tells us about CytomX Therapeutics IncJuly 2025 Levels & Weekly Momentum Stock Picks - Newser
CytomX Therapeutics (NASDAQ:CTMX) Stock Crosses Below Fifty Day Moving AverageHere's Why - MarketBeat
Will Windtree Therapeutics Inc. outperform during market ralliesJuly 2025 Short Interest & Fast Moving Trade Plans - خودرو بانک
Market Outlook: Will CytomX Therapeutics Inc. benefit from AI trendsJuly 2025 Gainers & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Is CytomX Therapeutics Inc. trading at a discountJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - خودرو بانک
Will CytomX Therapeutics Inc. bounce back from current supportPortfolio Risk Report & Safe Entry Trade Signal Reports - Newser
Cytomx Therapeutics Inc Azioni (CTMX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):